Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Fresh Tracks Therapeutics Inc (FRTX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.8801 -0.0299    -3.29%
15/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 26,927
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.8801 - 0.9300
Fresh Tracks Therapeutics 0.8801 -0.0299 -3.29%

Fresh Tracks Therapeutics Inc Company Profile

 
Get an in-depth profile of Fresh Tracks Therapeutics Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

13

Equity Type

ORD

Fresh Tracks Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops FRTX-02 (BBI-02), an oral DYRK1A inhibitor that is completed Phase 1 clinical trials for the treatment of autoimmune and inflammatory diseases; FRTX-10 (BBI-10), a covalent stimulator of interferon genes inhibitor for the potential treatment of autoinflammatory and rare genetic diseases; and FRTX-03, a topical DYRK1A inhibitor for the treatment of mild-to-moderate skin conditions, as well as next-generation kinase inhibitors. Fresh Tracks Therapeutics, Inc. has license and collaboration agreements with Carna Biosciences, Inc., and Voronoi Inc. The company was formerly known as Brickell Biotech, Inc. and changed its name to Fresh Tracks Therapeutics, Inc. in September 2022. Fresh Tracks Therapeutics, Inc. was founded in 2009 and is headquartered in Boulder, Colorado.

Contact Information

Address 5777 Central Avenue Suite 102
Boulder, 80301
United States
Phone 720 505 4755
Fax -

Top Executives

Name Age Since Title
Albert Nicholas Marchio 71 2022 CEO, CFO, Secretary & Chairman
Bridget Wagner - 2022 Member of Scientific Advisory Board
Bernard Khor - 2022 Member of Scientific Advisory Board
Pui Lee - 2022 Member of Scientific Advisory Board
Peter A. Nigrovic - 2022 Member of Scientific Advisory Board
Katherine Fitzgerald - 2022 Member of Scientific Advisory Board
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

FRTX Comments

Write your thoughts about Fresh Tracks Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Alon Oahyo
Alon Oahyo Jul 06, 2022 12:24PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
going back to 1$?
Johny Cash
Johny Cash Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why falling it is?
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
because it's a scam
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
they will put it down to 0.001
Johny Cash
Johny Cash Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
after they can to buy cheaper
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Johny Cash probably next week it will be half from today
Alon Oahyo
Alon Oahyo Jul 01, 2022 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
0.000001
Duane Goodson
Duane Goodson Jun 23, 2022 10:37AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
She getting ready to pop.
Cody Sutton
Cody Sutton May 04, 2022 5:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MASSIVE run incoming
Ron Welt
Ron Welt Apr 19, 2022 8:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Told ya now let's see how it goes from here.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
Ron Welt
Ron Welt Mar 21, 2022 2:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
moving on up.
grafitx esposito
grafitx esposito Jan 18, 2022 2:49PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
MP’s initial magnetics facility in Fort Worth, Texas, will source materials from Mountain Pass, California, restoring a fully integrated U.S. supply chainMP has entered a long-term agreement with General Motors to supply U.S.-sourced and manufactured rare earth alloy and magnets to power more than a dozen models using GM’s Ultium PlatformThe facility will produce NdFeB alloy and magnets with the potential to power approximately 500,000 EV motors per year; a gradual production ramp is expected to begin in 2023
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email